Nursing Education Programs

Cancer Chemotherapy and Biotherapy
Education Programs

Option I:

Two Day Didactic Oncology Nursing Society's (ONS) Chemotherapy and Biotherapy Course

This course provides a comprehensive review of the knowledge needed to administer cytotoxic and biotherapeutic agents.

ONS will award 13.5 contact hours to nurses who attend this program in its entirety. ONS is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider number 2580.

ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Course Objectives

Upon completion of the course, the participant will be able to:

  • Identify various therapeutic modalities used to treat cancer with emphasis on chemotherapy and biotherapy
  • Describe the investigational process all drugs undergo to gain approval for use
  • Review ethical and legal issues related to cancer therapy
  • Identify factors affecting response to cancer therapy
  • Identify selected commonly used agents, their mechanisms of action, and any unique administration issues
  • Discuss safety precautions necessary when handling cytotoxic agents
  • Review chemotherapy dose calculations and practice examples
  • Identify nursing procedures and interventions for administering cytotoxic and biologic agents
  • Discuss two immediate complications of cancer therapy, extravasation and hypersensitivity, and the nursing measures required to prevent and/or reduce these complications
  • Identify selected systematic side effects of cytotoxic and biotherapeutic agents and the nursing interventions required to manage these side effects
  • Review specific patient and family education that may prevent and/or reduce the impact of systemic side effects

Click here for full brochure

Click here for registration form

 

Option II:

Eight Day Wake Forest University Comprehensive Cancer Center Cancer (CCCWFU) Chemotherapy and Biotherapy Course

(3 Didactic Days and 5 Day Clinical Practicum)

Intended to complement the ONS Chemotherapy and Biotherapy Course and by design focus on the ambulatory infusion nurse’s learning needs.  

CCCWFU will award 49 contact hours to nurses who attend this program in its entirety.

The Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University is an approved provider of continuing nursing education by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Prerequisite

Attendees must have successful completed of ONS Chemotherapy and Biotherapy Course with updated provider card.  Acceptance into the five-day clinical practicum is contingent on meeting the following established criteria:

  • Completed copy of the Nurse Sponsor Agreement
  • A copy of the participant’s nursing license from his/her state of employment
  • A certificate of professional liability insurance, in an amount no less than $1 million per occurrence and $3 million in the aggregate/year
  • Completed and signed copy of immunization record

Course Objectives

Upon completion of the course, the participant will be able to:

  • Discuss the mode of action, preparation, route of administration, side effects, and special precautions of the chemotherapy and biotherapy agents
  • Describe NIOSH Alert recommendations, OSHA Hazard Communication Standard and ASHP Guidelines on handling hazardous drugs (HDs)
  • Understand proper technique when working with HDs in Biological Safety Cabinets)
  • Discuss the proper use of close system devices for preparation and administration of HDs)
  • Describe the use of an HD spill kit and the precautions required when cleaning a spill)
  • Determine strategies to disinfect and decontaminate work surfaces)
  • Identify appropriate practices for safe handling of bodily fluids of patients receiving hazardous drugs)
  • Discuss internal and external central venous catheters: types, indications, management, and complications)
  • Review the criteria for management of common complications of central venous catheters)
  • Discuss the major psychosocial issues relating to cancer and cancer treatment)
  • Calculate drug dosages and cumulative doses based on the patient’s weight or body surface area)
  • Identify patient compliance issues with oral medications and its impact on the oncology patient)
  • Define health care illiteracy)
  • Review key components for developing patient education materials)
  • Identify the role of the nurse in clinical trials)
  • Discuss the economics as related to chemotherapeutic and biotherapeutic agents)

Click here for a full brochure

Click here for registration form

 

Options III:

Two Day Didactic Oncology Nursing Society's (ONS) Chemotherapy and Biotherapy Course plus CCCWFU Cancer Chemotherapy and Biotherapy Course

(3 Day Didactic and 5 Day Clinical Practicum)

Two week Chemotherapy Class

Week One

 

Monday and TuesdayWednesday -Friday

Oncology Nursing Society's (ONS) Chemotherapy and Biotherapy Course

(Two Day Didactic)

This course provides a comprehensive review of the knowledge needed to administer cytotoxic and biotherapeutic agents. 

ONS will award 13.5 contact hours to nurses who attend this program in its entirety. ONS is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider number 2580.

ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Course Objectives

Upon completion of the course, the participant will be able to:

  • Identify various therapeutic modalities used to treat cancer with emphasis on chemotherapy and biotherapy.
  • Describe the investigational process all drugs undergo to gain approval for use.
  • Review ethical and legal issues related to cancer therapy.
  • Identify factors affecting response to cancer therapy.
  • Identify selected commonly used agents, their mechanisms of action, and any unique administration issues.
  • Discuss safety precautions necessary when handling cytotoxic agents.
  • Review chemotherapy dose calculations and practice examples.
  • Identify nursing procedures and interventions for administering cytotoxic and biologic agents.
  • Discuss two immediate complications of cancer therapy, extravasation and hypersensitivity, and the nursing measures required to prevent and/or reduce these complications.
  • Identify selected systematic side effects of cytotoxic and biotherapeutic agents and the nursing interventions required to manage these side effects.
  • Review specific patient and family education that may prevent and/or reduce the impact of systemic side effects.

 

CCCWFU Cancer Chemotherapy and Biotherapy Course

(Three Day Didactic)

This course is intended to complement the ONS Chemotherapy and Biotherapy Course and by design focus on the ambulatory infusion nurse’s learning needs.  

CCCWFU will award 49 contact hours to nurses who attend this program in its entirety.

The Section on Hematology and Oncology, Comprehensive Cancer Center of Wake Forest University is an approved provider of continuing nursing education by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Acceptance into the five-day clinical practicum is contingent on meeting the following established criteria:

  • Completed copy of the Nurse Sponsor Agreement                               
  • A copy of the participant’s nursing license from his/her state of employment. 
  • A certificate of professional liability insurance, in an amount no less than $1 million per occurrence and $3 million in the aggregate/year.
  • Completed and signed copy of immunization record

Course Objectives

Upon completion of the course, the participant will be able to:

  • Discuss the mode of action, preparation, route of administration, side effects, and special precautions of the chemotherapy and biotherapy agents. 
  • Describe NIOSH Alert recommendations, OSHA Hazard Communication Standard and ASHP Guidelines on handling hazardous drugs (HDs)
  • Understand proper technique when working with HDs in Biological Safety Cabinets.
  • Discuss the proper use of close system devices for preparation and administration of HDs
  • Describe the use of an HD spill kit and the precautions required when cleaning a spill
  • Determine strategies to disinfect and decontaminate work surfaces
  • Identify appropriate practices for safe handling of bodily fluids of patients receiving hazardous drugs. 
  • Discuss internal and external central venous catheters: types, indications, management, and complications.
  • Review the criteria for management of common complications of central venous catheters.
  • Discuss the major psychosocial issues relating to cancer and cancer treatment. 
  • Calculate drug dosages and cumulative doses based on the patient’s weight or body surface area.
  • Identify patient compliance issues with oral medications and its impact on the oncology patient.
  • Define health care illiteracy.
  • Review key components for developing patient education materials. 
  • Identify the role of the nurse in clinical trials. 
  • Discuss the economics as related to chemotherapeutic and biotherapeutic agents

 

Week Two

 

Each participant will be paired with a preceptor in each of the following clinical areas:

  • Outpatient Infusion
  • Inpatient Chemotherapy Team
  • Central Venous Catheter Care Team
  • Clinical Coordinating

If requested, participants will have the opportunity to mix chemotherapy/biotherapy agents.

 

Click here for full brochure

Click here for registration form

Quick Reference

School of Medicine
Student Admissions

336-716-4264

medadmit@wakehealth.edu

Student Financial Planning

336-716-2889

finaid@wakehealth.edu

Student Services

336-716-4271

stuserv@wakehealth.edu

Location:
3rd Floor Watlington Hall
Wake Forest Baptist Medical Center
Medical Center Blvd.
Winston-Salem, NC 27157-1090
Find A Doctor Ways to Give
Last Updated: 11-21-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.